Read more – Ambrose Cheung, professor of microbiology and immunology, has received a 2017 Harrington Scholar-Innovator Award from the Harrington Discovery Institute at University Hospitals in Cleveland. Cheung will receive up to $700,000 over the next two years to develop a compound to help in the fight against MRSA, a collection of commonly occurring staph bacteria that causes difficult-to-treat infections.
Articles by: Geisel Communications
NH Docs Debate Safe Drug-Use Rooms in Hospitals – New Hampshire Union Leader
Read article – Quotes Tim Lahey, associate professor of medicine, microbiology and immunology, and of the Dartmouth Institute for Health Policy and Clinical Practice, who is encouraging health care professionals to consider a unique approach to helping patients by establishing safe drug-use rooms inside of hospitals. Safe injection rooms in hospitals would not be his first option, but Lahey said it should be explored further—a view not shared by some New Hampshire health experts. “I think the evidence is clear that safe injection facilities improve outcomes in people with addiction, and do not have the harms that people imagine,” said Lahey. “I encourage these debates so that we can weigh the pros and cons.”
Negative Impact of Food Commercials on Toddlers – Counsel & Heal
Read article – Jennifer Emond, assistant professor of pediatrics and of biomedical data science, is quoted in regards to research she conducted that found preschoolers in the United States are exposed to unhealthy eating habits at a young age through TV advertisements and print ads.
Far Fewer Men Being Treated for Prostate Cancer – Reuters Health
Read article – Quotes H. Gilbert Welch, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, in an article about a new study that shows the number of older Americans treated for prostate cancer plummeted 42 percent since health officials began questioning the benefits of screening tests.
2017 Red Dress Award Honorees – Woman’s Day
Read article – Holly S. Andersen DC’85, a member of the Geisel School of Medicine Board of Overseers and director of education and outreach for the Ronald O. Perelman Heart Institute at Presbyterian Hospital–Weill Cornell Medical Center, will be one of the many women honored at the Woman’s Day Red Dress Awards. Andersen is one of the country’s top advocates for women’s heart health, and a leading authority on preventive cardiology.
Proxi App Places Friends and Family on Mental Health Care Teams
“We see this as a way to transform mental health treatment,” says Geisel’s William Hudenko.
Dartmouth Celebrates MLK With Justice Rally – Valley News
Read article – Quotes Ahmad Dbouk, Geisel ’19, about the keynote speech given by Tim Wise as part of Dartmouth College’s celebration of Martin Luther King Jr. Dbouk said Wise’s speech gave him a complete historical context for how white-dominated culture has driven a wedge between blacks and whites. “He really drew a lot of lines to the dots that I kind of had,” said Dbouk.
At the Hospitals: Doctors Named to D-H Boards – Valley News
Read story – Kari Rosenkranz, associate professor of surgery, and Jon Wahrenberger, assistant professor of medicine, have been elected to Dartmouth-Hitchcock health system’s boards. Rosenkranz was elected to a three-year term as a trustee, and Wahrenberger was named to a four-year term on the board of governors
Using Hypothermia to Save Gunshot Victims, Treating Addicts, & the Bookshelf (Audio) – NHPR
Original story – As a guest on “Word of Mouth,” Tim Lahey, associate professor of medicine, microbiology and immunology, and of the Dartmouth Institute for Health Policy and Clinical Practice, discusses why he believes opioid users should be allowed to inject while in hospital care.
Sanofi Inks Autoimmune Collab That Could Mean $0.5B in Payments for ImmuNext – Genetic Engineering and Biotechnology News
Read article – Quotes Randolph Noelle, professor of microbiology and immunology, in an article about how ImmuNext, a company he co-founded, entered into an agreement with Sanofi to develop a novel protein for the treatment of autoimmune disorders.